Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132446) titled 'Shanghai Clinical Cohort - Prostate Cancer Specialised Demonstration Cohort Development' on Sept. 14.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: The Cancer Hospital, Fudan University
Condition:
Prostate cancer
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2025-07-03
Target Sample Size: Prostate Cancer:3500;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=291622
Published by HT Digital Content Services with permission from Health Daily Digest....